等待开盘 10-29 09:30:00 美东时间
-2.740
-2.63%
Effective immediately, CPT 31242 is no longer considered experimental, removing a key barrier for ENT physicians treating chronic rhinitis. GALWAY, Ireland, Oct. 22, 2025 /PRNewswire/ --
10-23 00:08
(来源:小张聊科研) 今天我们来梳理国自然科研热点“代谢重编程”的高分文章研究。 靶向NPM1表观遗传学促进心肌梗死后心脏修复。 研究主要关注N...
10-16 09:04
今日重点评级关注:花旗:维持Arcus Biosciences"买入"评级,目标价从47美元升至54美元;HC Wainwright & Co.:上调Karyopharm Therapeutics评级至"买入",目标价15美元
10-14 09:56
Evercore ISI Group analyst Steve Sakwa maintains Camden Prop Trust (NYSE:CPT) with a In-Line and lowers the price target from $116 to $115.
10-13 20:29
三石 发自 凹非寺 量子位 | 公众号 QbitAI 当全球的目光还在聚焦基座模型的参数竞赛时,一场更为深刻的变革正在悄然发生——后训练(Post-Train...
10-13 16:45
(来源:金融小博士) 节后投资指南:四大黄金赛道全解析,产业链核心标的深度扫描 假期尾声渐近,全球科技与大宗商品市场的剧烈波动已提前点燃A股投资者的情绪。从...
10-08 09:00
An update from EchoIQ Limited ( ($AU:EIQ) ) is now available. Echo IQ announced...
10-06 11:48
AngioDynamics (ANGO) exceeds expectations, raises guidance for fiscal 2026 with positive cash flow expected.
10-04 00:47
今日重点评级关注:JMP证券:维持Ocular Therapeutix"跑赢大市"评级,目标价从20美元升至29美元;汇丰银行:上调Banco BBVA Argentina评级至"买入",目标价从21美元下调至17美元
10-02 15:08
Camden Prop Trust (NYSE:CPT) has been analyzed by 17 analysts in the last three...
10-02 03:00